Evidence map›Paper›PMID 30774678›Full record

ArticleIranian journal of pathology2018

Designing and Construction of a Cloning Vector Encoding

Faria Hasanzadeh Haghighi, Ehsan Aryan, Mohammad Derakhshan, Aida Gholoobi, Zahra Meshkat

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Iranian journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Immunoinformatics analysis of the proteins MPT83 and MPT51 to design a possible chimeric vaccine against Mycobacterium tuberculosis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Faria Hasanzadeh HaghighiAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Ehsan AryanAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad DerakhshanAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Aida GholoobiDept. of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Zahra MeshkatAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mashhad University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

objectiveTuberculosis (TB) remains a major cause of death around the world. Bacillus Calmette Guérin (BCG) is the only vaccine used in TB prevention that has a protective effect in children, but its effectiveness declines in adults. Design and development of new vaccines is the most effective way against TB.The aim of this study was to design and construct a DNA vaccine encoding

methodsFirst,

resultsUsing agarose gel electrophoresis, a 926 bp fragment corresponded to

conclusionIn this study, we constructed a cloning vector encoding

Indexed as

AntigensCloningGenetic vectorsMycobacterium tuberculosis

Identifiers

PMID30774678
PMCPMC6358561
OpenAlexW2896378879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.